Cargando…

Improving Outcomes in Patients with CRC: The Role of Patient Reported Outcomes—An ESDO Report

Colorectal cancer is one of the most commonly diagnosed cancers worldwide and nearly half of patients will develop metastatic disease at some point during the course of their disease. The goal of anticancer therapy in this context is to extend survival, while trying to maximise the patient’s health-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Van Cutsem, Eric, De Gramont, Aimery, Henning, Geoffrey, Rougier, Philippe, Bonnetain, Franck, Seufferlein, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5483878/ https://www.ncbi.nlm.nih.gov/pubmed/28587143 http://dx.doi.org/10.3390/cancers9060059

Ejemplares similares

STRATEGIC-1: A multiple-lines, randomized, open-label GERCOR phase III study in patients with unresectable wild-type RAS metastatic colorectal cancer
por: Chibaudel, Benoist, et al.
Publicado: (2015)

Time to Definitive Health-Related Quality of Life Score Deterioration in Patients with Resectable Metastatic Colorectal Cancer Treated with FOLFOX4 versus Sequential Dose-Dense FOLFOX7 followed by FOLFIRI: The MIROX Randomized Phase III Trial
por: Hamidou, Zeinab, et al.
Publicado: (2016)

Maximising clinical benefit with adequate patient management beyond the second line in mCRC
por: Argiles, Guillem, et al.
Publicado: (2019)

New curative approach using embolization followed by moderate-dose radiotherapy after surgical failure for large right heart metastasis
por: Delanian, Sylvie, et al.
Publicado: (2021)

MAINTENANCE HORMONAL TREATMENT IMPROVES PROGRESSION FREE SURVIVAL AFTER A FIRST LINE CHEMOTHERAPY IN PATIENTS WITH METASTATIC BREAST CANCER
por: Dufresne, Armelle, et al.
Publicado: (2008)

Quality of life with encorafenib plus cetuximab with or without binimetinib treatment in patients with BRAF V600E-mutant metastatic colorectal cancer: patient-reported outcomes from BEACON CRC
por: Kopetz, S., et al.
Publicado: (2022)

Imaging in Colorectal Cancer: Progress and Challenges for the Clinicians
por: Van Cutsem, Eric, et al.
Publicado: (2016)

Could baseline health-related quality of life (QoL) predict overall survival in metastatic colorectal cancer? The results of the GERCOR OPTIMOX 1 study
por: Diouf, Momar, et al.
Publicado: (2014)

Induction therapy with cetuximab plus docetaxel, cisplatin, and 5-fluorouracil (ETPF) in patients with resectable nonmetastatic stage III or IV squamous cell carcinoma of the oropharynx. A GERCOR phase II ECHO-07 study
por: Chibaudel, Benoist, et al.
Publicado: (2015)

Distribution- and anchor-based methods to determine the minimally important difference on patient-reported outcome questionnaires in oncology: a structured review
por: Ousmen, Ahmad, et al.
Publicado: (2018)

Evaluation of the Role of Circulating Tumor Cells and Microsatellite Instability Status in Predicting Outcome of Advanced CRC Patients
por: Messaritakis, Ippokratis, et al.
Publicado: (2020)

Improving diagnosis, prognosis and prediction by using biomarkers in CRC patients
por: Nikolouzakis, Taxiarchis Konstantinos, et al.
Publicado: (2018)

Microbial Dysbiosis in Colorectal Cancer (CRC) Patients
por: Sobhani, Iradj, et al.
Publicado: (2011)

CRC6: The 28 Years Observation of a Maxillectomy Patient: A Case Report
por: Tani, Hiroko, et al.
Publicado: (2018)

CRC concise encyclopedia of mathematics
por: Weisstein, Eric W
Publicado: (2003)

CRC concise encyclopedia of mathematics
por: Weisstein, Eric W
Publicado: (1999)

Intrinsic bevacizumab resistance is associated with prolonged activation of autocrine VEGF signaling and hypoxia tolerance in colorectal cancer cells and can be overcome by nintedanib, a small molecule angiokinase inhibitor
por: Mésange, Paul, et al.
Publicado: (2014)

PEPCOL: a GERCOR randomized phase II study of nanoliposomal irinotecan PEP02 (MM‐398) or irinotecan with leucovorin/5‐fluorouracil as second‐line therapy in metastatic colorectal cancer
por: Chibaudel, Benoist, et al.
Publicado: (2016)

Association of post-operative CEA with survival and oxaliplatin benefit in patients with stage II colon cancer: a post hoc analysis of the MOSAIC trial
por: Auclin, Edouard, et al.
Publicado: (2019)

Multimodal Treatment in Metastatic Colorectal Cancer (mCRC) Improves Outcomes—The University College London Hospital (UCLH) Experience
por: Joharatnam-Hogan, Nalinie, et al.
Publicado: (2020)

Providing Hospitalized Ulcerative Colitis Patients With Practice Guidelines Improves Patient-Reported Outcomes
por: Weizman, Adam V, et al.
Publicado: (2020)

Impact of geography on prognostic outcomes of 21,509 patients with metastatic colorectal cancer enrolled in clinical trials: an ARCAD database analysis
por: Yin, Jun, et al.
Publicado: (2021)

Identification of DNA methylation markers for early detection of CRC indicates a role for nervous system-related genes in CRC
por: Rademakers, Glenn, et al.
Publicado: (2021)

Patient-Reported Outcomes of Liposuction for Lipedema Treatment
por: Kirstein, Fiona, et al.
Publicado: (2023)

CRC handbook of microbiology
Publicado: (1988)

Patient-Reported Outcomes (PROs) and Patient-Reported Outcome Measures (PROMs)
por: Weldring, Theresa, et al.
Publicado: (2013)

AMCP Partnership Forum: Improving Quality, Value, and Outcomes with Patient-Reported Outcomes
Publicado: (2018)

CRC Screening Results: Patient Comprehension and Follow-up
por: Azulay, Revital, et al.
Publicado: (2019)

Health-related quality of life assessment for patients with advanced or metastatic renal cell carcinoma treated with a tyrosine kinase inhibitor using electronic patient-reported outcomes in daily clinical practice (QUANARIE trial): study protocol
por: Mouillet, Guillaume, et al.
Publicado: (2019)

CRC13: Management of Snoring with Novel Mandibular Advancement Device in a Bruxing Patient: A Case Report
por: Kashmoola, Sayfaldeen, et al.
Publicado: (2018)

CRC9: Management of Trigeminal Neuralgia in a Patient after Lower Tooth Extraction: A Case Report
por: Winardi, Agrippina Maria, et al.
Publicado: (2018)

CRC8: Sectional Impression for a Total Maxillectomy Patient Reconstructed with Free Flap: A Clinical Report
por: Hsieh, Pei-Ni, et al.
Publicado: (2018)

Clinical Outcome Assessment in Cancer Rehabilitation and the Central Role of Patient-Reported Outcomes
por: Lehmann, Jens, et al.
Publicado: (2021)

Dynamics in treatment response and disease progression of metastatic colorectal cancer (mCRC) patients with focus on BRAF status and primary tumor location: analysis of untreated RAS-wild-type mCRC patients receiving FOLFOXIRI either with or without panitumumab in the VOLFI trial (AIO KRK0109)
por: Kurreck, A., et al.
Publicado: (2020)

Improving the overall survival prognosis prediction accuracy: A 9‐gene signature in CRC patients
por: Zheng, Wenbo, et al.
Publicado: (2021)

Selinexor, a selective inhibitor of nuclear export, enhances the anti-tumor activity of olaparib in triple negative breast cancer regardless of BRCA1 mutation status
por: Marijon, Hélène, et al.
Publicado: (2021)

Patient-Reported Outcomes in Foot and Ankle Orthopedics
por: Lakey, Eric, et al.
Publicado: (2019)

Systemic vasculitis and patient-reported outcomes: how the assessment of patient preferences and perspectives could improve outcomes
por: Robson, Joanna C, et al.
Publicado: (2019)

Patient-reported outcome measures in arthroplasty registries: Report of the Patient-Reported Outcome Measures Working Group of the International Society of Arthroplasty RegistriesPart I. Overview and rationale for patient-reported outcome measures
por: Rolfson, Ola, et al.
Publicado: (2016)

Observational report: Improved outcomes of transscleral cyclophotocoagulation for glaucoma patients
por: Bendel, Rick Edward, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_09mectbpp3gjt17tmilk6n6d93